between Drosophila melanogaster and Anopheles gambiae, although the X chromosome of the latter is smaller (18) . Thus, we can test the idea of preferential loss of male-biased genes from the X chromosome. It is noteworthy that there have been translocations from X chromosome to autosome (and vice versa) in the two lineages, which have allowed us to determine if movement to an autosome "rescues" X-chromosome male-biased genes from loss. When we plotted the ratio of sex-biased expression in Drosophila gonads against the probability that a homolog exists in Anopheles, two clear correlations were observed. In agreement with traditional comparative studies on limited numbers of genes (19) , genes highly expressed in males appear to change rapidly. More surprising is the strikingly tight correlation between degree of sex-biased expression and conservation.
Overall, 60% (8513) of the Drosophila transcripts represented on the array have homologs in Anopheles (18) . When we tracked changes in linkage between the species, we found that conservation is directly related to sex-biased expression ratios and to chromosomal location. The poorest conservation is between Drosophila X-chromosome male-biased genes and the Anopheles X chromosome (Fig. 4A) . Indeed, none of the X-chromosome genes showing greater than eightfold overexpression in Drosophila males are found on the Anopheles X chromosome, but this is not restricted to highly male-biased genes. There is a smooth inverse relationship between degree of male-biased expression and conservation. Translocation to an autosome clearly increases the probability of conservation. The only homologs of Drosophila genes with highly male-biased expression found on the Anopheles X chromosome are autosomal in Drosophila (Fig. 4B) , and nearly 30% of Drosophila X chromosome, male-biased genes are conserved on an Anopheles autosome (Fig. 4C) . The best-conserved malebiased genes are autosomal in both species (Fig.  4D) . Thus, continued X linkage of a gene with male-biased expression in both lineages, presumably reflecting the configuration of the ancestral X chromosome, is highly disfavored. These data unambiguously indicate that X linkage lowers the effective "life-span" of a gene with male-biased expression. Movement to the autosomes can occur by translocation or by preferential retrotransposition of male-biased genes as has been recently shown (20) .
It has been postulated that the X chromosome is a favored location for evolution of male advantage alleles because of the lack of a less advantageous second allele at that locus in hemizygotes (3). Indeed, in mammals it appears that the X chromosome is the favored location for male-biased expression, at least for a few genes expressed in primary spermatocytes (4) . However, this may be because of compensation, in advance, for the precocious inactivation of those X chromosomes in preparation for meiosis (20) .
It certainly seems clear that the X chromosome is a poor location for male-biased gene expression in C. elegans, and in late spermatocytes of Drosophila and humans, where X-chromosome inactivation has been implicated (11, 12, 15, 20) . However, X inactivation does not explain the paucity of X-chromosome genes showing male-biased expression in the Drosophila soma, or indeed in the bulk of spermatogenesis.
There are multiple forces shaping the X chromosome. Our data suggest that at least some of them result in demasculinization, because of net selection against extant, or poor net de novo creation of, male-biased genes. Although such antagonistic selection has been proposed as a force for masculinizing the X chromosome, or feminizing a chromosome with restricted passage through females, it is easily adapted to the idea of demasculinization. Because the X chromosome is present in females two-thirds of the time, there is pressure against genes with male-biased expression that are detrimental to females. However, it seems odd that those genes showing the most malebias, and therefore generally showing the lowest expression in females, would be subjected to the strongest negative selection in females. Is leaky expression of genes directing male development sufficiently detrimental to females to be selected against? How can the X chromosome not be favored for de novo male-biased genes, when hemizygosity means that even normally recessive genes are "dominant" and thus subjected to immediate selection in males? Clearly, the sequencing and expression profiles of more organisms to develop better models of the ancestral X chromosome will greatly aid the unraveling of these and other long-standing questions of sex chromosome origin and divergence. The structure of Escherichia coli succinate dehydrogenase (SQR), analogous to the mitochondrial respiratory complex II, has been determined, revealing the electron transport pathway from the electron donor, succinate, to the terminal electron acceptor, ubiquinone. It was found that the SQR redox centers are arranged in a manner that aids the prevention of reactive oxygen species (ROS) formation at the flavin adenine dinucleotide. This is likely to be the main reason SQR is expressed during aerobic respiration rather than the related enzyme fumarate reductase, which produces high levels of ROS. Furthermore, symptoms of genetic disorders associated with mitochondrial SQR mutations may be a result of ROS formation resulting from impaired electron transport in the enzyme. (4, 5) . In Caenorhabditis elegans, the mev-1 mutant, which has a point mutation in the SdhC subunit, is reported to be hypersensitive to oxygen and to develop a premature aging phenotype (6, 7) . Although it has been suggested that these disorders can be caused by oxidative stress produced by complex II itself (2) , no detailed molecular mechanism has been proposed.
Succinate dehydrogenase is closely related to fumarate reductase (menaquinol:fumarate oxidoreductase or QFR), which catalyzes the opposite reaction to that of SQR during anaerobic respiration in bacteria (8) . SQR and QFR are suggested to have evolved from a common ancestor (9) , and in E. coli they are capable of functionally replacing each other (10, 11) . The hydrophilic SdhA and SdhB subunits exhibit strong sequence similarity to their QFR counterparts; however, the sequences of transmembrane subunits are less well conserved. The structures of QFR from both E. coli (containing no heme) and Wolinella succinogenes (containing two hemes) have been solved to 2.7 and 2.2 Å, respectively (12, 13) . Two spatially separated menaquinonebinding sites have been identified in the E. coli QFR structure (12, 13) , but the quinone-binding site position(s) in the W. succinogenes structure has yet to be determined. In many bacteria, including E. coli, and in parasites like Ascaris suum, SQR is expressed and used under aerobic conditions but QFR is used under anaerobic conditions (1, 8, 14, 15) . Because both SQR and QFR can catalyze the same reactions in vivo and in vitro, it has been unclear why cells would need to produce SQR under aerobic conditions.
Here, we report the structure of SQR from E. coli at 2.6 Å resolution. Details of sample preparation, crystallization, and structure determination are provided in (16) . Statistics for data collection and structure determination are summarized in Table 1 .
The overall structure of SQR is shown in Fig. 1 , A and B. SQR is packed as a trimer (total molecular weight 360 kD), with the monomers related by a crystallographic three-fold axis. This distinguishes the SQR structure from the reported QFR structures, which form dimers (12) . The trimer shows a mushroom-like shape, with the largest dimensions 125 Å along the membrane and 125 Å along the membrane normal. The monomers are very tightly packed, with a contact surface of 1242 Å 2 , and this observation suggests that this trimer association is physiological.
Although the structures of the SdhA and SdhB subunits of SQR are similar to those of E. coli (17) 
where Ii(h) is the ith measurement.
‡The last shell R merge for the high-resolution set is rather high as a result of strong anisotropy. However, we include the data for the refinement because the refinement R-factor and R free for the shell is reasonably low, which indicates the data in this shell are still useful for the refinement.
§Phasing power is the r.m.s. value of F h divided by the r.m.s. lack-of-closure error.
ԽԽAll the observed reflections are used for the refinement.
#R free was calculated for 1% of reflections randomly excluded from the refinement. All redox centers and the succinate and quinone-binding sites are clearly assigned in the electron density map (Fig. 1C) . The SdhA subunit contains a covalently attached flavin adenine dinucleotide (FAD) cofactor and the substrate-binding site. In the crystal structure, density at the substrate-binding site was assigned as oxaloacetate, an inhibitor of SQR that remains bound during the purification process (18 (Fig. 1C) . All edge-to-edge distances between the centers are less than the suggested 14 Å limit for physiological electron transfer (22) . In contrast, the shortest distance between metal centers in adjacent monomers is 30.4 Å (edge-to-edge for heme b), which indicates that electron transfer likely occurs within each monomer.
Unexpectedly, heme b is not located in this pathway. It seems that the electron transfer pathway is branched at the [3Fe-4S] cluster to ubiquinone and heme b. Edge-to-edge distance between the [3Fe-4S] cluster and ubiquinone is 7.6 Å, shorter than the 11.4 Å between the [3Fe-4S] cluster and heme b. Additionally, ubiquinone has a higher redox potential (ϳ ϩ100 mV) than does heme b (ϩ36 mV). Although electrons can be transferred either to ubiquinone or to heme b from the [3Fe-4S] cluster, transfer to ubiquinone is preferable. Mutants of heme b ligands strongly affect the heme potential but nonetheless permit SQR activity, suggesting that flux through the heme b is not essential for quinone reduction (23) . All known SQR complexes contain at least one heme b; however, this is not the case for QFR. Because E. coli QFR is stable without a heme b, the presence of heme may not be an absolute structural requirement for complex II. The physiological importance of this heme b is discussed below.
The SdhC and SdhD subunits form a membrane-bound cytochrome b with six transmembrane helices containing one heme b group and a ubiquinone-binding site (Fig. 3, A and B) . Two well-ordered phospholipid moleculesone cardiolipin (a prevalent lipid in the inner membrane of mitochondria and bacteria) and one phosphatidylethanolamine-were also observed. Two acyl groups of cardiolipin occupy the hydrophobic space below the heme b, which accommodates the second heme b in the W. succinogenes QFR structure.
Electron density assigned as ubiquinone is located in a cleft composed of residues from three subunits, SdhB, SdhC, and SdhD, close to the [3Fe-4S] cluster (Fig. 3, A and B) . When the enzyme was co-crystallized with a competitive inhibitor of ubiquinone, 2-(1-methylhexyl)-4,6-dinitrophenol (DNP-17) (24), the density for the inhibitor was found at the same position, confirming this site as the physiological quinone-binding site (Fig. 3C) . The side chains of Tyr D83 and Trp B164 are direct ligands of the O1 atom of ubiquinone (Fig. 3, C  and D) . Tyr D83 forms an additional hydrogen bond to Arg C31, which could reduce the pK a of Tyr D83 side chain; therefore, a proton may directly be translocated from the Tyr D83 to the O1 atom of ubiquinone when it is reduced. The Arg C31 side chain is within 4 Å of a methoxy group of ubiquinone. This seems to be important for the substrate specificity of the ubiquinone-binding site. In the DNP-17 complex structure, Arg C31 recognizes the 6-nitro group of the inhibitor and is likely to be a key residue for substrate and inhibitor specificity. Arg C31 forms a salt bridge to a heme b propionate. The ubiquinone-binding site of the E. coli SQR is the first example of a tyrosine side chain functioning as a quinone ligand. Many quinonebinding sites reported to date have a His residue hydrogen bonded to the O1 or O4 carbonyl groups (25) . There is no protein side chain in proximity to the O4 carbonyl oxygen. It is possible that a water molecule is the O4 ligand as observed in the menaquinone-binding site in formate dehydrogenase-N (26). The O4 atom is close to the surface and could be directly connected to the cytoplasm by a water chain.
The quinone ring is sandwiched by Ile C28 and Pro B160 (Fig. 3D) . These residues, along with Ile B209, Trp B163, Trp B164, and Ser C27 (C␤ atom), form the hydrophobic environment of the quinone-binding pocket. The residues in the quinone-binding site, His B207, Pro B160, Trp B163, Trp B164, Ile B209, Ile C28, Arg C31, Tyr D83, and Asp D82, are strictly conserved among human, mouse, Paracoccus denitrificans, and E. coli SQRs. Mutation of the residue equivalent to Pro B160 in humans causes hereditary paraganglioma (27) . Mutation of the residue equivalent to Ile C28 in C. elegans (mev-1) results in a loss of ubiquinone reductase activity (6) and increased ROS production (7). These results strongly indicate that mitochondrial SQRs have the same ubiquinone-binding site as E. coli SQR.
In contrast, the residues in this region are poorly conserved in QFRs. In E. coli QFR, two menaquinone-binding sites, one on the periplasmic side (Q D site) and the other on the cytoplasmic side (Q P site), have been determined (12) . Both menaquinone-binding sites are different from the SQR ubiquinonebinding site; even the Q P site is about 15 Å away from the SQR ubiquinone-binding site when both enzymes are superimposed by program O (17), based on the C␣ atom positions in the hydrophilic subunits (12) . The position equivalent to the Q P site is occupied by the heme b propionate in the SQR structure. For W. succinogenes QFR, where the quinonebinding site has yet to be determined, a position equivalent to the SQR ubiquinonebinding site does not exist (13) . This enzyme has a single integral membrane subunit, and a horizontal helix connecting helices III and IV, making this site totally inaccessible from the outside. These results suggest that the SQR quinone-binding site is different from those of QFRs, which distinguishes SQR from QFR within this family of enzymes.
On the basis of the structure of SQR, the genetic mutations causing hereditary paraganglioma/pheochromocytoma (2, 28) can be classified into (i) nonsense mutations that produce truncated proteins, which fundamentally disrupt the structure of the transmem- brane subunits and/or association of the catalytic domain subunits SdhAB to the membrane; (ii) point mutations in the quinone-binding site; and (iii) point mutations around heme b. Interestingly, all of these mutations result in the same phenotype, indicating that they all cause the same problem to the cell. In the C. elegans mev-1 mutant, SQR can oxidize succinate to fumarate but cannot transfer electrons to ubiquinone. The observed increased ROS level is explained by the leakage of electrons, which are released from succinate but not accepted by ubiquinone because of the dysfunctional binding site. It has been suggested that the human genetic disorders that result from mutations of SdhB, SdhC, and SdhD subunits are also induced by ROS formation (2) .
The detailed mechanism of superoxide formation by the SQR/QFR family has recently been studied (29) . QFR can function perfectly well as an SQR as far as enzymatic activity is concerned (1) and, indeed, E. coli can grow aerobically in the complete absence of SQR when QFR is expressed instead (10) . However, while oxidizing succinate under aerobic conditions, E. coli QFR produces hydrogen peroxide (which SQR does not produce) and 25 times as much superoxide as E. coli SQR (29) . It was concluded that ROS is formed primarily at the FAD level because it is suppressed by an excess of substrate or substrate analogs. This is a logical conclusion, because many other flavoenzymes are known to be major sources of ROS.
The key difference between SQR and QFR lies in the arrangement of redox potentials among the redox centers ( Table 2 ). E. coli SQR maintains the high redox potential centers ([3Fe-4S] and heme b, which would attract electrons) close to the quinone-binding site. In contrast, in E. coli QFR, FAD and the [2Fe-2S] cluster have the highest redox potentials. These arrangements are favorable for the respective physiological catalytic reactions (i.e., ubiquinone reduction for SQR and fumarate reduction/menaquinol oxidation for QFR) but are not essential because both enzymes can catalyze the QFR and SQR reactions.
To quantify the effect, we calculated the electron distribution among the redox centers (Table 2) . For this calculation, we assumed that two electrons have been transferred from succinate to FAD but that the quinone site is not occupied (16) . Table 2 shows the number of electrons distributed on each of the redox centers of SQR and QFR under this condition. In the case of SQR, electrons are immediately removed from FAD to the [3Fe-4S] cluster and heme b, and only 0.02 electrons stay at FAD (i.e., 98% of FAD stays oxidized). However, for QFR, 1.0 electron/FAD is observed; thus, the reactive electron density is 50 times greater at the FAD where electrons are accessible to molecular oxygen because the FAD is directly exposed to the solvent. The situation should be similar during enzymatic catalysis, as intramolecular electron transfer is expected to be faster than turnover (21) . This evidence strongly suggests that the buildup of electrons around FAD is the cause of high-level ROS production by QFR, as suggested by Messner and Imlay (29) . This explains why bacteria and parasites use QFR under anaerobic conditions, where it is more efficient for fumarate reduction, and SQR under aerobic conditions, which produces considerably less ROS.
It seems that there has been evolutionary pressure for aerobic organisms to choose SQR over QFR to limit the formation of damaging ROS. A possible reason that all known SQRs conserve one or two hemes, even though heme is not in the direct electron transfer pathway between succinate and ubiquinone, could be to prevent ROS formation. In Table 2 , we have calculated the electron distribution among the redox centers for SQR without heme b. Without heme, electrons could build up on FAD and, in this case, 0.18 electrons would stay at FAD, which is nine times as high as when heme is present. Thus, heme b could serve as an electron sink to prevent electron leakage. However, this electron-sink mechanism is less effective for mitochondrial SQRs because the b heme has a lower redox potential (-185 mV) (30) .
The site itself may also have been designed to prevent ROS formation. The ubiquinonebinding site could be a source of ROS formation, particularly if semiquinone, which is a reaction intermediate, is not stabilized. The Q P site in E. coli QFR does not contain an aromatic ring, which may be because semiquinone is only transiently stabilized in the QFR reaction, and in fact the semiquinone is known to be destabilized in the native enzyme (31) . On the other hand, it has been known for many years that mammalian SQR stabilizes a semiquinone during the quinone reduction reaction (32) . One of the reasons that SQR uses a different quinone-binding site from QFR is to incorporate Tyr D83, which could stabilize semiquinone. This tyrosine residue is conserved among all SQRs.
The structure of E. coli SQR has given the first clues to the molecular mechanisms of a wide range of genetic disorders caused by mutation of the enzyme. E. coli SQR is an ideal model system to study these disorders because of the ease of characterization of enzymatic and structural properties of the mutants.
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